Table 1.
Clinical Characteristics of the Three Patient Groups
| Patient subgroups: | TSH ≤0.03 μIU/mL | 0.03 < TSH ≤0.3 μIU/mL | 0.3 < TSH ≤5 μIU/mL | p-Value |
|---|---|---|---|---|
| Number of patients | 58 | 46 | 29 | |
| TNM stage I/II/III/IV | 12/8/9/29 | 31/3/5/7 | 26/3/0/0 | |
| Age (years) | 53 (13) | 48 (13) | 54 (15) | *ns |
| Body weight (kg) | 56.5 (11.8) | 61.4 (12.2) | 59.6 (9.9) | ns |
| BMI (kg/m2) | 22.5 (3.5) | 23.4 (3.4) | 23.9 (3.4) | ns |
| Sex (female/male) | 49/9 | 33/13 | 26/3 | ns |
| Menopause status (pre/post) | 15/34 | 18/15 | 9/17 | ns |
| LT4 dose (μg/kg/day) | 2.19 (0.58) | 2.10 (0.44) | 1.95 (0.63) | ns |
Values shown are mean (SD). Statistical significance was analyzed by the chi-square test (sex, menopausal status), unpaired t-test, or *Mann–Whitney U-test using Bonferroni corrections for multiple comparisons.
TSH, thyrotropin; BMI, body mass index; LT4, levothyroxine; ns, not significant; SD, standard deviation.